Filing 2022 Q4 compared to 2022 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
GINO LABRUZZO
CHIEF OPERATING OFFICER
Greenwich, Connecticut
14 Feb 2023
NOTE: COLUMN 4 FOR THE MSD ACQUISITION CORP WARRANTS POSITION REFLECTS THE MARKET VALUE OF $0.08 PER WARRANT. THE MARKET PRICE FOR THE UNDERLYING MSD ACQUISITION SHARES WAS $10.10. NOTE: COLUMN 4 FOR THE AFTERNEXT HEALTHTECH ACQUISI WARRANTS POSITION REFLECTS THE MARKET VALUE OF $0.08 PER WARRANT. THE MARKET PRICE FOR THE UNDERLYING AFTERNEXT HEALTHTECH ACQUISI SHARES WAS $10.02. NOTE: COLUMN 4 FOR THE RICE ACQUISITION CORP II WARRANTS POSITION REFLECTS THE MARKET VALUE OF $1.25 PER WARRANT. THE MARKET PRICE FOR THE UNDERLYING RICE ACQUISITION CORP II SHARES WAS $10.17.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.